Merck & Co., Inc.

NYSE: MRK
$81.15
-$0.02 (0.0%)
Closing price October 22, 2021
While the quantitative easing soon will begin to dwindle, it is highly unlikely the Federal Reserve actually will raise interest rates until 2023, so buying blue-chip stocks with solid total return...
The trading action late last week hints that a long-overdue market correction may be coming, so now may be the right time to take some profits and move to calmer waters. These five conservative...
Tuesday’s top analyst upgrades and downgrades included Amgen, Cirrus Logic, Hain Celestial, Johnson & Johnson, Lam Research, Merck, Spotify Technology and Vertex Pharmaceuticals.
These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for investors, especially now that the market is overbought and the slow seasonal market...
Two pharmaceutical companies and a top media firm are on tap to report quarterly results before markets open on Thursday.
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Tuesday, including Domino’s, Eli Lilly, Harley-Davidson, McDonald’s and Merck.
Among the stocks in Warren Buffett's Berkshire Hathaway portfolio are eight components of the Dow 30, and only three of those are in the green for the year to date.
Warren Buffett reduced Berkshire Hathaway's holdings in 13 stocks during the first quarter of this year. Here's how eight of those stocks have performed so far in the second quarter.
Investors can almost count on the taper tantrum selling when the Federal Reserve begins to slow the quantitative easing this year, and these five top Dow Jones industrials will be good stocks to be...
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including LendingTree, Merck, Micron Technology, Nvidia and Target.
Three of the four stocks in our Thursday morning earnings preview are components of the Dow Jones industrial average. The other is the third best-paying dividend stock among the S&P 500.
Wednesday's top analyst upgrades and downgrades included AbbVie, Alcoa, Anheuser Busch, Applied Materials, CyberArk, Fox, Merck, Paychex, ViacomCBS and Waste Management.
Here are five notable health care laggard stocks that appear to have plenty of upside potential. Most of them are dividend payers too.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
The 2021 Dogs of the Dow are now known, and investors who may want to follow this investing strategy have got some thinking to do.